Hengzhuang Wang

University of Copenhagen — Denmark

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index2.4kcitations36works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bacterial biofilms and quorum sensing(24), Antibiotic Resistance in Bacteria(18), Cystic Fibrosis Research Advances(9), Antibiotics Pharmacokinetics and Efficacy(7), Antimicrobial Peptides and Activities(7)

Publications36 total

Pharmacodynamic modeling of colistin and imipenem against <i>in vitro Pseudomonas aeruginosa</i> biofilms
2024· 1 citedOpen Access
Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapy
International Journal of Pharmaceutics·2024· 2 cited
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis
Journal of Antimicrobial Chemotherapy·2023· 8 citedOpen Access
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy
Clinical Infectious Diseases·2023· 39 citedOpen Access
Inhalable ciprofloxacin/polymyxin B dry powders in respiratory infection therapy
Acta Materia Medica·2023· 8 citedOpen Access
Effects of antibiotic treatment and phagocyte infiltration on development of Pseudomonas aeruginosa biofilm—Insights from the application of a novel PF hydrogel model in vitro and in vivo
Frontiers in Cellular and Infection Microbiology·2022· 3 citedOpen Access
Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections
International Journal of Pharmaceutics·2022· 23 citedOpen Access
Further Commentary
Pediatric Pulmonology·2019
P124 Effect of ceftazidime-avibactam on biofilm of AmpC hyperproducers Pseudomonas aeruginosa
Journal of Cystic Fibrosis·2019
Optimization of colistin dosing regimen for cystic fibrosis patients with chronic <i>Pseudomonas aeruginosa</i> biofilm lung infections
Pediatric Pulmonology·2019· 16 cited
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
Frontiers in Microbiology·2019· 25 citedOpen Access
Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients
Pediatric Pulmonology·2016· 11 cited
OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model
Antimicrobial Agents and Chemotherapy·2016· 68 citedOpen Access
WS02.5 Pharmacodynamics of ceftazidime combined with β-lactamase inhibitors in biofilm Pseudomonas aeruginosa in vitro
Journal of Cystic Fibrosis·2015· 1 citedOpen Access
Strategies for combating bacterial biofilm infections
International Journal of Oral Science·2014· 893 citedOpen Access
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
Advanced Drug Delivery Reviews·2014· 307 cited
62 A rapid biofilm antimicrobial susceptibility assay under 24 hours for cystic fibrosis patients with Pseudomonas aeruginosa lung infection
Journal of Cystic Fibrosis·2014Open Access
Pharmacokinetics and Pharmacodynamics of Antibiotics in Biofilm Infections of Pseudomonas aeruginosa In Vitro and In Vivo
Methods in molecular biology·2014· 27 cited
Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against<i>Pseudomonas aeruginosa</i>biofilms
Pathogens and Disease·2013· 81 citedOpen Access
Regulation of pqs quorum sensing via catabolite repression control in Pseudomonas aeruginosa
Microbiology·2013· 31 cited
page 1 of 2Next →

Frequent Co-authors

Niels Høiby(28), Oana Ciofu(13), Zhijun Song(10), Hong Wu(9), Claus Moser(7), Liang Yang(4), Peter Østrup Jensen(3), J. G. Coen van Hasselt(3), Hriday Bera(3), Dongmei Cun(3), Mingshi Yang(3), Yiqiang Chen(3), Wang Lizan(3), Kong Jinliang(3), Tim Tolker‐Nielsen(2), Martina Ulrich(2), Søren Molin(2), Joachim Riethmüller(2), Lotte F. Mandsberg(2), Hong Wu(2)